Citation Impact
Citing Papers
Pten Deficiency in Melanocytes Results in Resistance to Hair Graying and Susceptibility to Carcinogen-Induced Melanomagenesis
2008 StandoutNobel
Immune Rejection of Mouse Tumors Expressing Mutated Self
2009 StandoutNobel
The Basic Principles of Chimeric Antigen Receptor Design
2013
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
2010
Biological determinants of bladder cancer gene expression subtypes
2015
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
2015
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma
1998
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
The p16INK4a/CDKN2A tumor suppressor and its relatives
1998
Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis
2000
MYC on the Path to Cancer
2012 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
2007
Function of the c-Myc Oncogenic Transcription Factor
1999
Oncogenic kinase signalling
2001 StandoutNature
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
1998
Active targeting schemes for nanoparticle systems in cancer therapeutics
2008
The 2004 World Health Organization classification of lung tumors
2005 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
c-Myc promotes differentiation of human epidermal stem cells
1997
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
2006 StandoutNobel
Head and neck cancer
2008 Standout
CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling
2002
Cellular Senescence in Cancer and Aging
2007 Standout
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
2017
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Smad-dependent and Smad-independent pathways in TGF-β family signalling
2003 StandoutNature
Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen
2005
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
1997 StandoutNobel
Extensive Repertoire of Membrane-bound and Soluble Dendritic Cell-specific ICAM-3-grabbing Nonintegrin 1 (DC-SIGN1) and DC-SIGN2 Isoforms
2001
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
2011 StandoutNature
c-MYC: more than just a matter of life and death
2002
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
In vivo cancer targeting and imaging with semiconductor quantum dots
2004 Standout
Distinct Thresholds Govern Myc's Biological Output In Vivo
2008
c-Myc/Max Heterodimers Bind Cooperatively to the E-Box Sequences Located in the First Intron of the Rat Ornithine Decarboxylase (ODC) Gene
1997
TGF-β receptor signaling
1997
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
Bladder cancer
2016 Standout
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
2001
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Expression ofmyc-family,myc-interacting, andmyc-target genes during preimplantation mouse development
1997
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Immunotherapy for prostate cancer
2006
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
2012
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock
2011 StandoutNobel
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
2000 StandoutNobel
MicroRNA signatures in human cancers
2006 Standout
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
2018
Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
1999 StandoutNobel
Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen
2001
A microRNA polycistron as a potential human oncogene
2005 StandoutNature
Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation
2001
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
2013 StandoutNobel
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
1996
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
2015
Therapeutic T cell engineering
2017 Nature
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
1997
Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals
2007 Standout
Tumorigenesis and the angiogenic switch
2003 Standout
Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
1999
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse
2001
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
2003
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
SIN3-Dependent Transcriptional Repression by Interaction with the Mad1 DNA-Binding Protein
1996
Cancer Cell Cycles
1996 StandoutScience
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Telomerase activation: one step on the road to cancer?
1999 StandoutNobel
DC-SIGN from African Green Monkeys Is Expressed in Lymph Nodes and Mediates Infection intransof Simian Immunodeficiency Virus SIVagm
2003 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen
2006
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells
2010 StandoutNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Essential role for Max in early embryonic growth and development
2000
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Works of I Pellicer being referenced
Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
1997
Deletion of the p16 and p15 Genes in Human Bladder Tumors
1995
CD44 Isoform Expression Follows Two Alternative Splicing Pathways in Breast Tissue
1998
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer
1993
Contrasting roles for Myc and Mad proteins in cellular growth and differentiation.
1995
Prostate-specific membrane antigen expression in normal and malignant human tissues.
1997